These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 27432557)
1. Bacterial survival and distribution during buffy coat platelet production. Taha M; Kalab M; Yi QL; Maurer E; Jenkins C; Schubert P; Ramirez-Arcos S Vox Sang; 2016 Nov; 111(4):333-340. PubMed ID: 27432557 [TBL] [Abstract][Full Text] [Related]
2. Efficiency of riboflavin and ultraviolet light treatment against high levels of biofilm-derived Staphylococcus epidermidis in buffy coat platelet concentrates. Taha M; Culibrk B; Kalab M; Schubert P; Yi QL; Goodrich R; Ramirez-Arcos S Vox Sang; 2017 Jul; 112(5):408-416. PubMed ID: 28378343 [TBL] [Abstract][Full Text] [Related]
3. Elimination and multiplication of bacteria during preparation and storage of buffy coat-derived platelet concentrates. Mohr H; Bayer A; Gravemann U; Müller TH Transfusion; 2006 Jun; 46(6):949-55. PubMed ID: 16734811 [TBL] [Abstract][Full Text] [Related]
4. Activation during preparation of therapeutic platelets affects deterioration during storage: a comparative flow cytometric study of different production methods. Metcalfe P; Williamson LM; Reutelingsperger CP; Swann I; Ouwehand WH; Goodall AH Br J Haematol; 1997 Jul; 98(1):86-95. PubMed ID: 9233569 [TBL] [Abstract][Full Text] [Related]
5. Platelet storage lesion in interim platelet unit concentrates: A comparison with buffy-coat and apheresis concentrates. Singh S; Shams Hakimi C; Jeppsson A; Hesse C Transfus Apher Sci; 2017 Dec; 56(6):870-874. PubMed ID: 29126740 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components. Ramirez-Arcos S; Kou Y; Perkins H Vox Sang; 2014 Aug; 107(2):192-5. PubMed ID: 25040020 [TBL] [Abstract][Full Text] [Related]
7. Superior integrin activating capacity and higher adhesion to fibrinogen matrix in buffy coat-derived platelet concentrates (PCs) compared to PRP-PCs. Beshkar P; Hosseini E; Ghasemzadeh M Transfus Apher Sci; 2018 Feb; 57(1):76-81. PubMed ID: 29292029 [TBL] [Abstract][Full Text] [Related]
8. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Knutson F; Alfonso R; Dupuis K; Mayaudon V; Lin L; Corash L; Högman CF Vox Sang; 2000; 78(4):209-16. PubMed ID: 10895093 [TBL] [Abstract][Full Text] [Related]
9. pH value promotes growth of Staphylococcus epidermidis in platelet concentrates. Störmer M; Kleesiek K; Dreier J Transfusion; 2008 May; 48(5):836-46. PubMed ID: 18298602 [TBL] [Abstract][Full Text] [Related]
10. Markers of platelet activation and apoptosis during storage of apheresis- and buffy coat-derived platelet concentrates for 7 days. Albanyan AM; Harrison P; Murphy MF Transfusion; 2009 Jan; 49(1):108-17. PubMed ID: 18954396 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the platelet-rich plasma and buffy coat protocols for preparation of canine platelet concentrates. Hoareau GL; Jandrey KE; Burges J; Bremer D; Tablin F Vet Clin Pathol; 2014 Dec; 43(4):513-8. PubMed ID: 25267468 [TBL] [Abstract][Full Text] [Related]
12. Storage of platelet concentrates from pooled buffy coats made of fresh and overnight-stored whole blood processed on the novel Atreus 2C+ system: in vitro study. Sandgren P; Callaert M; Shanwell A; Gulliksson H Transfusion; 2008 Apr; 48(4):688-96. PubMed ID: 18194379 [TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature. Ojha S; Tirlotkar A; Gupta AM; S H S; Chavan P; Poojary M Transfus Apher Sci; 2021 Feb; 60(1):103014. PubMed ID: 33262053 [TBL] [Abstract][Full Text] [Related]
14. Rapid detection of bacterial contamination of platelet-rich plasma-derived platelet concentrates using flow cytometry. Lee HR; Seo JW; Kim MJ; Song SH; Park KU; Song J; Han KS Ann Clin Lab Sci; 2012; 42(2):174-81. PubMed ID: 22585614 [TBL] [Abstract][Full Text] [Related]
15. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169 [TBL] [Abstract][Full Text] [Related]
16. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method. Lu FQ; Kang W; Peng Y; Wang WM Transfusion; 2011 Oct; 51(10):2199-207. PubMed ID: 21492181 [TBL] [Abstract][Full Text] [Related]
17. Comparison of bacterial attachment to platelet bags with and without preconditioning with plasma. Loza-Correa M; Kalab M; Yi QL; Eltringham-Smith LJ; Sheffield WP; Ramirez-Arcos S Vox Sang; 2017 Jul; 112(5):401-407. PubMed ID: 28466544 [TBL] [Abstract][Full Text] [Related]
18. Soluble CD40L and CD62P levels differ in single-donor apheresis platelet concentrates and buffy coat-derived pooled platelet concentrates. Sut C; Tariket S; Aloui C; Arthaud CA; Eyraud MA; Fagan J; Chavarin P; Hamzeh-Cognasse H; Laradi S; Garraud O; Cognasse F Transfusion; 2019 Jan; 59(1):16-20. PubMed ID: 30291753 [TBL] [Abstract][Full Text] [Related]
19. [Qualitative comparison between buffy-coat-collected platelet concentrates and those by single-donor plateletpheresis]. Yu Y; Luo Q; Liu JH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):878-81. PubMed ID: 17708824 [TBL] [Abstract][Full Text] [Related]
20. Microparticle and mitochondrial release during extended storage of different types of platelet concentrates. Marcoux G; Duchez AC; Rousseau M; Lévesque T; Boudreau LH; Thibault L; Boilard E Platelets; 2017 May; 28(3):272-280. PubMed ID: 27681879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]